These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 995498)

  • 1. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution.
    Steele RW; Britton HA; Anderson CT; Kniker WT
    Pediatr Res; 1976 Dec; 10(12):1003-5. PubMed ID: 995498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cell activity in a male infant with T-and B-lymphocyte dysfunction treated with thymosin.
    Hanson LA; Lindholm L; Carlsson B; Fasth A; Fälström SP; Wadsworth C; Värendh G
    Scand J Immunol; 1976; 5(10):1227-31. PubMed ID: 1087748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunodeficiency with immunoglobulins: treatment with a thymus implant in millipore diffusion chambers.
    García Rodríguez MC; Fontán G; Alba J; Lorente F; Segurado E; García de Miguel MJ; Ojeda JA
    Allergol Immunopathol (Madr); 1979; 7(5):337-44. PubMed ID: 317215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes.
    Rubinstein A; Hirschhorn R; Sicklick M; Murphy RA
    N Engl J Med; 1979 Feb; 300(8):387-92. PubMed ID: 310515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immunodeficiency diseases by organ transplantation.
    Parkman R
    Prog Clin Immunol; 1977; 3():85-102. PubMed ID: 17139
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymosin therapy in the DiGeorge syndrome.
    Barrett DJ; Wara DW; Ammann AJ; Cowan MJ
    J Pediatr; 1980 Jul; 97(1):66-71. PubMed ID: 7381650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoparathyroidism with T-cell deficiency and hypoimmunoglobulinemia: response to thymosin therapy.
    Bonagura VR; Pitt J
    Clin Immunol Immunopathol; 1981 Mar; 18(3):375-86. PubMed ID: 6972840
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo studies with thymosin in cancer patients.
    Schafer LA; Goldstein AL; Gutterman JU; Hersh EM
    Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal thymus transplantations in severe combined immunodeficiency.
    Haneberg B; FROLAND SS; Finne PH; Bakke T; Thunold S; Moe PJ; Tonder O; Solberg CO; Solheim BG; Dalen A
    Scand J Immunol; 1976; 5(8):917-24. PubMed ID: 11548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreconstitution.
    Buckley RH
    Pediatr Clin North Am; 1977 May; 24(2):313-28. PubMed ID: 323803
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo responses to thymosin in severe combined immunodeficiency.
    Mawhinney H; Gleadhill VF; McCrea S
    Clin Immunol Immunopathol; 1979 Oct; 14(2):196-203. PubMed ID: 314879
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency.
    Rachelefsky GS; Stiehm ER; Ammann AJ; Cederbaum SD; Opelz G; Terasaki PI
    Pediatrics; 1975 Jan; 55(1):114-8. PubMed ID: 122863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic factors.
    Bach JF; Carnaud C
    Prog Allergy; 1976; 21():342-408. PubMed ID: 12517
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation.
    Taylor SG
    Med Pediatr Oncol; 1982; 10(2):171-4. PubMed ID: 6978456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
    Goldstein AL; Cohen GH; Rossio JL; Thurman GB; Brown CN; Ulrich JT
    Med Clin North Am; 1976 May; 60(3):591-606. PubMed ID: 131889
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
    Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
    Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.